About WuXi Diagnostics
WuXi Diagnostics is a company based in Rochester (United States) founded in 2018. WuXi Diagnostics has raised $200 million across 2 funding rounds from investors including Thermo Fisher Scientific, Shiyu Capital and ABC International Holdings. WuXi Diagnostics operates in a competitive market with competitors including BioSerenity, QuidelOrtho, NuvoAir, MedTel Healthcare and ProciseDx, among others.
- Headquarter Rochester, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$200 M (USD)
in 2 rounds
-
Latest Funding Round
$150 M (USD), Series B
Feb 23, 2021
-
Investors
Thermo Fisher Scientific
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of WuXi Diagnostics
WuXi Diagnostics has successfully raised a total of $200M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $150 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in WuXi Diagnostics
WuXi Diagnostics has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Thermo Fisher Scientific, Shiyu Capital and ABC International Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Shiyu Capital is engaged in equity investment and asset allocation.
|
Locked | Locked | Locked | |
|
Private equity investments are managed by Yunfeng Capital in China.
|
Locked | Locked | Locked | |
|
Sunland Capital is focused on early-stage healthcare industry investments.
|
Locked | Locked | Locked |
Investor details for WuXi Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by WuXi Diagnostics
Investment portfolio details for WuXi Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - WuXi Diagnostics
Detailed financials for WuXi Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Wuxi Diagnostics Comparisons
Peer comparison for WuXi Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of WuXi Diagnostics
WuXi Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioSerenity, QuidelOrtho, NuvoAir, MedTel Healthcare and ProciseDx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of smart healthcare solutions for sleep and EEG lab management
|
|
| Locked | Locked | Locked |
Provider of healthcare information services
|
|
| Locked | Locked | Locked |
Clinical decision support tools for respiratory diseases are provided.
|
|
| Locked | Locked | Locked |
Remote patient monitoring software is developed for healthcare providers.
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic devices for immunoassay tests are provided to clinicians.
|
|
| Locked | Locked | Locked |
ICT-based products and solutions are developed for healthcare.
|
Detailed competitors of WuXi Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Wuxi Diagnostics
Complete news archive for WuXi Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about WuXi Diagnostics
WuXi Diagnostics was founded in 2018 and raised its 1st funding round 1 year after it was founded.
WuXi Diagnostics is headquartered in Rochester, United States.
Jason Liu is the current CEO of WuXi Diagnostics.
WuXi Diagnostics is a funded company, having raised a total of $200M across 2 funding rounds to date.
Founded in 2018 and based in Rochester, United States, WuXi Diagnostics operates in the healthcare sector. Integrated diagnostic platforms are developed to support hospitals and physicians with data-driven decision-making for various diseases. Multi-platform technical and clinical big data are utilized, alongside products such as the Enabling Solution Package, which applies algorithms for early disease detection and management.
WuXi Diagnostics's top competitors include MedTel Healthcare, QuidelOrtho and Neurosynaptic.
WuXi Diagnostics has 7 investors. Key investors include Thermo Fisher Scientific, Shiyu Capital, ABC International Holdings, Yunfeng Capital, and Feixiang Group.